Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Marlex Pharmaceuticals, Inc.

Marlex Pharmaceuticals, Inc. Recalls

All product recalls associated with Marlex Pharmaceuticals, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Aug 2023

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–3 of 3 recalls

Digoxin Tablets 0.25mg (Marlex) – Label Mix-Up (2023)

Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP 0.125mg.

Class IIModerate

FDAAug 25, 2023Nationwide• Marlex Pharmaceuticals, Inc.

Digoxin Tablets 0.125mg (Marlex) – Label Mix-Up (2023)

Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP 0.125mg.

Class IHigh

FDAAug 25, 2023Nationwide• Marlex Pharmaceuticals, Inc.

Acetaminophen Tablets (Marlex) – manufacturing deviation (2013)

CGMP Deviations: The recalled acetaminophen tablet lot was not manufactured under current good manufacturing practices as noted by a recent inspection of the manufacturing firm.

Class IIModerate

FDAAug 8, 2013Nationwide• Marlex Pharmaceuticals, Inc.